ACOEM Member Price: $68.00
Non-Member Price: $90.00
Natalie Hartenbaum, MD, MPH, FACOEM
President and Chief Medical Officer
Nothing to disclose
Joseph Ojile, MD, DABSM, FCCP
Founder and CEO
Clayton Sleep Institute, LLC
Nothing to disclose
Emerson Wickwire, PhD
University of Maryland School of Medicine
DayZz: Scientific consulting; Merck: Research support to UMB; Scientific consulting; ResMed: Research support to UMB; WellTap: Equity shareholder
It is almost impossible for the occupational health professional to avoid encountering employees with or at risk of sleep disorders. Whether being asked to evaluate a driver who wants to use an implantable device for his obstructive sleep apnea; a hospital worker requesting an accommodation for shift-work disorder; or a machinist who keeps falling asleep at work (hint, he works 2 other jobs) we need to understand the current methods for diagnosing and treating sleep disorders. Corporate medical directors/advisors may be asked to weigh in on the value of implementing fatigue management programs or including sleep disorders in their wellness programs. This session will review the current methods for diagnosing and treating sleep disorders such as shift work disorder, insufficient sleep syndrome, insomnia, and obstructive sleep apnea. Regulatory and best practice in select industries will be discussed as will the economic impact of sleep disorders on the workplace. As a panel, the faculty will discuss issues such as workplace accommodation requests, and appropriateness of testing and treatment in certain workplace setting and will take questions from attendees.
1. Review the current methods for diagnosis and treatment for selected sleep disorders.
2. Discuss the economic impact of sleep disorders on health and safety.
3. Understand the regulatory/best practice requirements for addressing sleep disorders as they affect the workplace.
Earn up to 1.5 AMA PRA Category 1 Credits™ and/or ABPM LLSA Credits.
This activity expires April 30, 2022.